Assessing the incremental value of diagnostic and prognostic markers: a review and illustration

Applying the Lorenz curve to disease risk to optimize health benefits under cost constraints

(2013) Mitchell H. Gail   Statistics and Its Interface

Expectations, validity, and reality in omics

(2010) John P.A. Ioannidis   JOURNAL OF CLINICAL EPIDEMIOLOGY

Clinical validity: Defining biomarker performance

(2010) Patrick M. M. Bossuyt   SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION

Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers

(2010) Michael J. Pencina et al.   STATISTICS IN MEDICINE

Criteria for Evaluation of Novel Markers of Cardiovascular Risk

(2009) Mark A. Hlatky et al.   CIRCULATION

Assessing the Performance of Prediction Models

(2009) Ewout W. Steyerberg et al.   EPIDEMIOLOGY

Evaluating prediction models in reproductive medicine

(2009) S.F.P.J. Coppus et al.   HUMAN REPRODUCTION

Assessment of Claims of Improved Prediction Beyond the Framingham Risk Score

(2009) Ioanna Tzoulaki   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Putting Risk Prediction in Perspective: Relative Utility Curves

(2009) Stuart G. Baker   JNCI-Journal of the National Cancer Institute

Critical appraisal of CRP measurement for the prediction of coronary heart disease events: new data and systematic review of 31 prospective cohorts

(2008) Tina Shah et al.   INTERNATIONAL JOURNAL OF EPIDEMIOLOGY